Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Tolerance to antineoplastic agents in children and adults.

× No keyword cloud information.

13 in total

Review 1. The importance of phase I/II trials in pediatric oncology.

Authors: C A MacArthur; T Vietti
Journal: Invest New Drugs Date: 1996 Impact factor: 3.850

Review 2. Phase I trials in paediatric oncology--the European perspective. The New Agents Group of the United Kingdom Childrens Cancer Study Group.

Authors: E J Estlin; S Ablett; D R Newell; I J Lewis; L Lashford; A D Pearson
Journal: Invest New Drugs Date: 1996 Impact factor: 3.850

Review 3. New drug development for pediatric oncology.

Authors: S Weitman; L Carlson; C B Pratt
Journal: Invest New Drugs Date: 1996 Impact factor: 3.850

Review 4. Haemopoietic growth factors in paediatric oncology: a review of the literature.

Authors: L M Wagner; W L Furman
Journal: Paediatr Drugs Date: 2001 Impact factor: 3.022

Review 5. Optimizing drug development of anti-cancer drugs in children using modelling and simulation.

Authors: Johan G C van Hasselt; Natasha K A van Eijkelenburg; Jos H Beijnen; Jan H M Schellens; Alwin D R Huitema
Journal: Br J Clin Pharmacol Date: 2013-07 Impact factor: 4.335

Review 6. Pediatric drug development: a perspective from the Cancer Therapy Evaluation Program (CTEP) of the National Cancer Institute (NCI).

Authors: M Smith; P T Ho
Journal: Invest New Drugs Date: 1996 Impact factor: 3.850

7. Continual reassessment method vs. traditional empirically based design: modifications motivated by Phase I trials in pediatric oncology by the Pediatric Brain Tumor Consortium.

Authors: Arzu Onar; Mehmet Kocak; James M Boyett
Journal: J Biopharm Stat Date: 2009 Impact factor: 1.051

Review 8. Clinical pharmacokinetics of paclitaxel.

Authors: D S Sonnichsen; M V Relling
Journal: Clin Pharmacokinet Date: 1994-10 Impact factor: 6.447

9. Phase I study of temozolomide combined with oral etoposide in children with malignant glial tumors.

Authors: Antonio Ruggiero; Daniela Rizzo; Giorgio Attinà; Ilaria Lazzareschi; Palma Maurizi; Vita Ridola; Stefano Mastrangelo; Roberta Migliorati; Patrizia Bertolini; Cesare Colosimo; Riccardo Riccardi
Journal: J Neurooncol Date: 2013-05-12 Impact factor: 4.130

Review 10. Paclitaxel. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic potential in the treatment of cancer.

Authors: C M Spencer; D Faulds
Journal: Drugs Date: 1994-11 Impact factor: 9.546